MedPath

Remotely Supervised Exercise for Adults With Cystic Fibrosis

Not Applicable
Completed
Conditions
Cystic Fibrosis
Interventions
Other: Exercise
Registration Number
NCT05173194
Lead Sponsor
Universidad Europea de Madrid
Brief Summary

Cystic fibrosis (CF) is a genetic disease characterized by abnormal chloride transport in epithelial tissues. Inflammation is a key component contributing to the main alterations induced by the disease. The increase in life expectancy comes with a higher prevalence of CF-related comorbidities, but also with new emerging complications directly related to aging. Physical fitness and exercise practice have been previously associated to survival and better quality of life in patients with cystic fibrosis. Thus, the aim of this study is to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.

Detailed Description

This study aims to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Confirmed clinical and genetic diagnosis for cystic fibrosis;
  • Age from 16 years.
Exclusion Criteria
  • Musculoskeletal disorders that do not allow the performance of physical exercise;
  • Pregnancy;
  • Absence of registration of clinical required.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Telematic ExerciseExerciseA remotely supervised resistance exercise program will be carried out for 8 weeks, with three weekly sessions lasting approximately 60 minutes each. Training will be performed in groups of four patients, according to their lung function/physical fitness. The first training session will be on site (University) for familiarization, planning and adjustment of the exercises, and the following sessions will be performed online. Each session is divided into: (i) Warm-up and joint mobility; (ii) main part: strength exercises for different muscle groups; and (iii) cool down: stretching and breathing exercises.
Primary Outcome Measures
NameTimeMethod
Change in plasmatic levels of KlothoBaseline and 8 weeks

Change from baseline to 8 weeks

Change in peripheral muscle strength. Upper and lower limb muscle strength will be evaluated using the 5 maximum repetition test in specific strength machines. Handgrip strength will be measured with a dynamometer.Baseline and 8 weeks

Change from baseline to 8 weeks

Change in body composition (muscle mass and skeletal mass index - kg/m2) measured through dual-energy x-ray absorptiometry (DEXA)Baseline and 8 weeks

Change from baseline to 8 weeks

Change in plasmatic levels of interleukins (IL-8 and IL-10)Baseline and 8 weeks

Change from baseline to 8 weeks

Secondary Outcome Measures
NameTimeMethod
Change in Pulmonary Function (Lung Function)Baseline and 8 weeks

Change from baseline to 8 weeks

Change in quality of life evaluated using the Cystic Fibrosis Questionnaire (CFQ-R +14). Scores range from 0 to 100 with higher scores corresponding to better quality of life.Baseline and 8 weeks

Change from baseline to 8 weeks

Change in inspiratory muscle strength (MIP)Baseline and 8 weeks

Change from baseline to 8 weeks

Change in functional capacity (30 seconds sit-to-stand test)Baseline and 8 weeks

Change from baseline to 8 weeks

Trial Locations

Locations (1)

Hospital La Princesa

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath